Background Over the past decade, advances in risk characterization, surveillance strategies
and treatment alternatives have rapidly transformed the management of differentiated …

An individualized assessment of the risk of recurrence and the risk of dying from thyroid
cancer is the cornerstone of nearly all management decisions in differentiated thyroid cancer …

Abstract Background and Objectives The recent de‐escalation of care for differentiated
thyroid cancer (DTC) has broadened the range of initial treatment options. We examined the …

Objective To understand patient perspective regarding recommended changes in the 2015
American Thyroid Association (ATA) guidelines. Specifically, in regard to active surveillance …

Objective: To present clinical outcomes of the prospective implementation of the 2015
American Thyroid Association (ATA) guidelines for the management of thyroid nodules and …

Accuracy in the prediction of adverse oncologic outcomes has been a challenge in
endocrine neoplasia, where a complex web of factors including host-dependent variables …

Background This systematic review and meta-ethnography investigates the decision-making
process surrounding treatment for low-risk differentiated thyroid cancer (DTC), especially as …

In 2015, the American Thyroid Association (ATA) published evidence-based guidelines for
the management and follow-up of patients with differentiated thyroid cancer (DTC)[1]. While …

Background Up to 30% of differentiated thyroid cancer (DTC) will develop advanced-stage
disease (aDTC) with reduced overall survival (OS). Objective The aim of this study is to …

The American Joint Cancer Committee (AJCC) staging system is widely used and has
proven to be useful in predicting disease-specific survival for differentiated thyroid cancer …